# Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)

> **NCT06799234** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Oxford** · enrollment: 240 (actual)

## Conditions studied

- Rift Valley Fever

## Interventions

- **BIOLOGICAL:** ChAdOx1 RVF
- **BIOLOGICAL:** Rabies Vaccine

## Key facts

- **NCT ID:** NCT06799234
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-08
- **Primary completion:** 2026-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799234, "Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06799234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*